cognitive cybersecurity intelligence

News and Analysis

Search

Weight-Loss Drugs Aren’t Really About Weight

Weight-Loss Drugs Aren’t Really About Weight

While GLP-1 drugs can aid weight loss, their high cost and side effects present challenges. The drugs could be beneficial to people with excess visceral fat who are at risk of chronic illnesses. Most insurance providers do not cover GLP-1s and they are intended for lifetime use. Another problem is identifying who needs GLP-1s, as the primary metric for determining candidates is weight, despite BMI being an inaccurate measure of body fat and the detrimental visceral fat.

Source: www.theatlantic.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts